Nisa Investment Advisors’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5
| Closed | -$107 | – | 2988 |
|
|
2024
Q2 | $107 | Sell |
5
-2
| -29% | -$62 | ﹤0.01% | 2876 |
|
|
2024
Q1 | $435 | Buy |
7
+3
| +75% | +$129 | ﹤0.01% | 2526 |
|
|
2023
Q4 | $89 | Buy |
+4
| New | +$60 | ﹤0.01% | 2619 |
|
|
2023
Q3 | – | Sell |
-127
| Closed | -$8.58K | – | 2795 |
|
|
2023
Q2 | $8.58K | Buy |
127
+14
| +12% | +$5.79K | ﹤0.01% | 2282 |
|
|
2023
Q1 | $53K | Hold |
113
| – | – | ﹤0.01% | 1697 |
|
|
2022
Q4 | $45K | Sell |
113
-2
| -2% | -$766 | ﹤0.01% | 1808 |
|
|
2022
Q3 | $47K | Buy |
115
+3
| +3% | +$966 | ﹤0.01% | 1754 |
|
|
2022
Q2 | $30K | Buy |
112
+88
| +367% | +$22.5K | ﹤0.01% | 1909 |
|
|
2022
Q1 | $7K | Sell |
24
-10
| -29% | -$3.49K | ﹤0.01% | 2255 |
|
|
2021
Q4 | $13K | Hold |
34
| – | – | ﹤0.01% | 1995 |
|
|
2021
Q3 | $9 | Sell |
34
-180
| -84% | -$63.8K | ﹤0.01% | 2213 |
|
|
2021
Q2 | $142 | Buy |
214
+160
| +296% | +$92.2K | ﹤0.01% | 1542 |
|
|
2021
Q1 | $47 | Sell |
54
-88
| -62% | -$93.7K | ﹤0.01% | 1991 |
|
|
2020
Q4 | $131K | Buy |
142
+28
| +25% | +$29.4K | ﹤0.01% | 1627 |
|
|
2020
Q3 | $117K | Buy |
114
+15
| +15% | +$16.1K | ﹤0.01% | 1496 |
|
|
2020
Q2 | $100K | Buy |
99
+17
| +21% | +$15.8K | ﹤0.01% | 1447 |
|
|
2020
Q1 | $71K | Sell |
82
-7
| -8% | -$6.96K | ﹤0.01% | 1462 |
|
|
2019
Q4 | $95K | Sell |
89
-67
| -43% | -$68.4K | ﹤0.01% | 1446 |
|
|
2019
Q3 | $144K | Buy |
156
+137
| +721% | +$150K | ﹤0.01% | 1397 |
|
|
2019
Q2 | $21K | Buy |
19
+6
| +46% | +$6.57K | ﹤0.01% | 1600 |
|
|
2019
Q1 | $18K | Sell |
13
-234
| -95% | -$317K | ﹤0.01% | 1629 |
|
|
2018
Q4 | $286K | Hold |
247
| – | – | ﹤0.01% | 1149 |
|
|
2018
Q3 | $375K | Buy |
247
+234
| +1,800% | +$360K | ﹤0.01% | 1175 |
|
|
2018
Q2 | $20K | Hold |
13
| – | – | ﹤0.01% | 1540 |
|
|
2018
Q1 | $15K | Sell |
13
-12
| -48% | -$15.8K | ﹤0.01% | 1528 |
|
|
2017
Q4 | $29K | Hold |
25
| – | – | ﹤0.01% | 1489 |
|
|
2017
Q3 | $33K | Hold |
25
| – | – | ﹤0.01% | 1470 |
|
|
2017
Q2 | $20K | Buy |
25
+10
| +67% | +$6.97K | ﹤0.01% | 1487 |
|
|
2017
Q1 | $9K | Sell |
15
-13
| -46% | -$7.92K | ﹤0.01% | 1697 |
|
|
2016
Q4 | $15K | Buy |
+28
| New | +$14K | ﹤0.01% | 1717 |
|
Other funds holding KYNB
AC
6CM
GC
Nisa Investment Advisors's KYNB Position: Q3 2024 in Review
Nisa Investment Advisors sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 5 shares — an estimated $107 sold.
Nisa Investment Advisors first reported a position in KYNB in Q4 2016 and held it in 30 quarters. The position peaked at $375K in Q3 2018. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.
- Nisa Investment Advisors reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
- Nisa Investment Advisors sold 5 Kyntra Bio shares in Q3 2024, an estimated $107.
- Nisa Investment Advisors first reported a position in Kyntra Bio in Q4 2016 and held it in 30 quarters.
- Nisa Investment Advisors's Kyntra Bio position peaked at $375K in Q3 2018.
- 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.
Based on Nisa Investment Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.